Actera Ingredients, Inc.

Actera Ingredients, Inc. creates innovative, science-backed ingredients and custom formulations for the cosmetics and personal care sectors, emphasizing safety and efficacy in beauty and skincare products. Actera Ingredients, Inc. specializes in providing customized ingredient solutions for the cosmetics industry.

Founded in 2017 in the United States by Daniel Winn, the company has undergone a strategic focus on enhancing product offerings and technological advancements. Actera has completed one investment deal, with the most recent occurring on August 12, 2019, when Arcline Investment Management invested an undisclosed amount. Actera Ingredients, Inc. specializes in science-backed ingredients and custom formulations designed for the cosmetics and personal care industries.

The company offers a range of products that include bioactive botanicals, clean preservatives, and functional and sensory formulation services, all aimed at enhancing the efficacy and safety of beauty and skincare products. Their offerings cater to the needs of various clients, including manufacturers and brands looking for innovative solutions to address aging, skin health, and overall consumer wellness. Actera's products are positioned within key markets across North America, Europe, and Asia, targeting both established cosmetic brands and emerging enterprises that prioritize sustainability and performance in their formulations. Actera Ingredients, Inc.

generates revenue through direct partnerships with cosmetic and personal care brands, as well as collaborations with manufacturers seeking customized ingredient solutions. The business model typically involves B2B transactions where clients integrate Actera's formulations into their finished products, contributing to a streamlined supply chain. Transactions are structured around project-based agreements or ongoing contracts that may involve bulk purchasing of core ingredients or tailored formulation services. Pricing structures are determined based on the complexity of the formulations and the volume of ingredients required, reflecting the premium nature of their science-backed offerings.

Flagship products may include proprietary blends of bioactive ingredients designed to target specific skin concerns, positioning Actera as a leader in the formulation of innovative personal care solutions. Actera Ingredients, Inc. is focused on launching new products that enhance their line of bioactive ingredients, with plans to introduce these innovations over the next year. The company intends to expand its presence in key markets such as Southeast Asia and Europe by 2025, targeting partnerships with both established brands and new entrants in the cosmetics industry.

The funding received from Arcline Investment Management in August 2019 will be utilized to support these initiatives, enabling Actera to enhance its research and development capabilities and facilitate market entry strategies.